摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-N-(2-甲氧基苯基)喹唑啉-4-胺 | 827030-62-6

中文名称
2-氯-N-(2-甲氧基苯基)喹唑啉-4-胺
中文别名
——
英文名称
2-chloro-N-(2-methoxyphenyl)quinazolin-4-amine
英文别名
(2-chloro-quinazolin-4-yl)-(2-methoxy-phenyl)-amine
2-氯-N-(2-甲氧基苯基)喹唑啉-4-胺化学式
CAS
827030-62-6
化学式
C15H12ClN3O
mdl
——
分子量
285.733
InChiKey
PPIVYXPCJGGBBH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    47
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:22473ce8595f445a0bdbfdce1b0c828d
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold
    摘要:
    A series of compounds with quinazoline scaffold were designed, synthesized and evaluated as novel potent 5-HT2A receptor ligands. N-(4-Chlorophenyl)-2-(piperazin-1-yl)quinazolin-4-amine (5o) has a K-i value of 14.04 +/- 0.21 nM, with a selectivity more than 10,000 fold over 5-HT1A receptors (D-1 and D-2-like receptors). The functional assay showed that this compound is an antagonist to 5-HT2A receptor with an IC50 value of 1.66 mu M. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.07.030
  • 作为产物:
    描述:
    2,4-喹唑啉二酮三正丙胺三乙胺三氯氧磷 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 4.0h, 生成 2-氯-N-(2-甲氧基苯基)喹唑啉-4-胺
    参考文献:
    名称:
    Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold
    摘要:
    A series of compounds with quinazoline scaffold were designed, synthesized and evaluated as novel potent 5-HT2A receptor ligands. N-(4-Chlorophenyl)-2-(piperazin-1-yl)quinazolin-4-amine (5o) has a K-i value of 14.04 +/- 0.21 nM, with a selectivity more than 10,000 fold over 5-HT1A receptors (D-1 and D-2-like receptors). The functional assay showed that this compound is an antagonist to 5-HT2A receptor with an IC50 value of 1.66 mu M. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.07.030
点击查看最新优质反应信息

文献信息

  • 一种2,4-二取代喹唑啉类衍生物及其制备方法和在抗肿瘤药物中的应用
    申请人:陈爱平
    公开号:CN111848585A
    公开(公告)日:2020-10-30
    本发明属于药物技术领域,尤其涉及一种2,4‑二取代喹唑啉类衍生物及其在抗肿瘤药物中的应用。具体为抗肺癌、抗胃癌、抗卵巢癌、抗乳腺癌、抗直肠癌等抗肿瘤作用效果。MTT实验显示,本发明合成的FAK抑制剂对肿瘤细胞的抑制率比较理想,具有临床开发抗肿瘤药物的前景。
  • COMPOUNDS AND THERAPEUTICAL USE THEREOF
    申请人:Cai Xiong Sui
    公开号:US20070244113A1
    公开(公告)日:2007-10-18
    Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
    本发明揭示了4-芳氨基喹唑啉及其类似物,可有效激活半胱氨酸蛋白酶并诱导细胞凋亡。本发明的化合物在治疗各种临床情况中具有用途,其中异常细胞的不受控制的生长和扩散。
  • Compounds and therapeutical use thereof
    申请人:Cai Xiong Sui
    公开号:US20050137213A1
    公开(公告)日:2005-06-23
    Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
    本发明揭示了4-芳基氨基喹唑啉及其类似物,它们有效地激活半胱氨酸蛋白酶并诱导细胞凋亡。本发明的化合物在治疗各种临床病症中具有用途,其中发生异常细胞的不受控制的生长和扩散。
  • METHOD OF TREATING BRAIN CANCER
    申请人:Cai Sui Xiong
    公开号:US20080051398A1
    公开(公告)日:2008-02-28
    Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to the use of these compounds in treating brain cancer.
    本发明涉及4-芳基氨基喹唑啉及其类似物,其有效激活caspases并诱导细胞凋亡。本发明的化合物可用于治疗各种临床病症,其中发生异常细胞的不受控制的生长和扩散,特别是用于治疗脑癌。
  • 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
    申请人:Myriad Pharmaceuticals, Inc.
    公开号:US07618975B2
    公开(公告)日:2009-11-17
    Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
    本发明揭示了4-芳基氨基喹唑啉及其类似物,其作为caspase激活剂和诱导凋亡剂具有有效性。本发明的化合物在治疗各种临床病症中有用,其中发生异常细胞的不受控制的生长和扩散。
查看更多